| Literature DB >> 32595590 |
Matthieu Faillot1,2, Silvia Morar1,2, Sebastien Delphine3, Mounir El-Mendili4, Denis Ducreux5, Fabrice Parker1,2, Nozar Aghakhani1,2.
Abstract
Object: Predicting whether intramedullary slitlike cavity (SC) will worsen over time or remain stable is an outstanding clinical challenge. The aim of this study was to identify early features of SC (clinical and magnetic resonance imaging [MRI] findings).Entities:
Keywords: DTI; MRI; intramedullary slitlike cavity; spinal cord; syringomyelia
Year: 2020 PMID: 32595590 PMCID: PMC7304370 DOI: 10.3389/fneur.2020.00495
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Patient with a typical slitlike cavity.
Figure 2Patient with an atypical slitlike cavity.
Comparison of our results with the literature.
| Jinkins and Sener ( | 3 | 27 (18–35) | 2/1 | 66%(2) | None | None | None | 33% (1) | NA | 2.6 (2–3) | Cervical: 33% (1) Thoracic: 66% (2) | NA | 3 (2–4) years | All | No | No |
| Petit Lacour et al. ( | 12 | 34 (14–65) | 10/2 | 58% (7) | 58% (7) | 8% (1) | 16% (2) | 0 | 2–4 (available in 2 patients, others = filiform) | 4.6 (2–11) | Cervical: 16% (2) Thoracic: 58% (7) Both: 25% (3) | NA | 9 years for one patient only | Yes (for one patient only) | No | No |
| Roser et al. ( | 40 | 36 (11–62) | 25/15 | #66% | 0 | NA | 10% | 2.7 (1.2–5.8) | 3.5 | Cervical: 23% Thoracic: 51% Both: 25% | normal | 36.9 months (6–93) | All | No (worsening of pain) | No | |
| Holly and Batzdorf ( | 32 | 40 (16–63) | 14/18 | 41% (13) | 22% (7) | 44% (20) minor motor deficits | 31% (10) | NA | 2 (1–5) | 3 (1–9) | 16 cervical 12 thoracic 4 both (patients missing) | NA | 38 months (6–110) | 78% (25) | 22% (7) | No |
| Magge et al. ( | 48 | 9.7 (0.2–19.3) | 30/18 | 27% (13) | 31% (15) (neurol. Symptoms) | NA | 12% (6) | 4 (1.2–9.4) | 7.1 (2–17) | Cervical: 4% (2) Thoracic: 63% (30) Both: 33% (16) | NA | 15.5 months (3–56)23.8 months (2–64) | NA | |||
| Klekamp ( | 635 | 40.8 ± 14.8 | 2/1 | 79.5% | NA | 10% | NA | NA | NA | NA | Cervical: 23% Thoracic: 70% Both: 7% | normal | No follow-up | |||
| Joseph et al. ( | 39 | 10.6 (3–16) | 25/14 | 36% (14) | NA | NA | NA | 64% (25) | 3.30 (1.1–7) | 2–19 | Cervical 8% (3) Thoracic 84% (33) Both 8% (3) | NA | 15.6 months (4–84) | 97% (38) | 3% (1) | No |
| Our study | 48 | 44.7 (12–68) | 29/19 | 60% (29) | 48% (23) | 15% (7) | NA | 2% (1) | 4.12 (1.5–7) | 4.8 (1–18) | Cervical: 27% (13) Thoracic: 46% (22) Both: 27% (13) | NA | 58 (6–344 m) | 81% (39) | 19% (9) | No |
Figure 3Clinical exam upon presentation and clinical evolution of patients.
Relationship between clinical parameters and imaging.
| Typical imaging | 26 | 2 | |
| Atypical imaging | 13 | 7 | |
| Positive predictive value = 0.35 | |||
| Negative predictive value = 0.93 | |||
Comparison of our preliminary Diffusion Tensor Imaging data with the literature.
| Agosta et al. ( | Syrinx (MS) | Normal | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Roser et al. ( | SC/control | NA | NA | NA | NA | NA | 0,53/0,52 | NA | NA | NA | 0,19 | NA | NA | NA | NA | NA | NA | NA |
| Hatem et al. ( | Syringomyelia/control | NA | 0,39/0,45 | 0,90/0,96 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Our study | SC | Artifact in all patients | 0,38 | 1,79 | 1,32 | 2,18 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Our study after segmentation | NA | 0,54 | 1,41 | 1,04 | 2,27 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |